SCHEMBL29655119

SCHEMBL29655119

COc1ccc(-c2ccc(N)c([N+](=O)[O-])c2)c(F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.54
TDP1 Q9NUW8 3/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
POLB P06746 1/20 0.54
ALDH1A1 P00352 4/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
AMY1A P0DUB6 1/20 0.46
TSHR P16473 1/20 0.44
EIF4E P06730 1/20 0.44
CYP3A4 P08684 1/20 0.43
ALOX15 P16050 1/20 0.43
HTR7 P34969 1/20 0.43
NPSR1 Q6W5P4 1/20 0.41
RAB9A P51151 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ERN1 O75460 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29655083 0.85 TDP1 (0.55) MAPTTDP1MEN1KMT2APOLB
SCHEMBL29655271 0.82 TDP1 (0.62) MAPTTDP1MEN1KMT2APOLB
SCHEMBL27963778 0.82 ALDH1A1 (0.62) MAPTTDP1MEN1KMT2APOLB
SCHEMBL717794 0.82 MAPT (0.71) MAPTTDP1MEN1KMT2APOLB
SCHEMBL204041 0.81 ALDH1A1 (0.61) MAPTTDP1MEN1KMT2APOLB
SCHEMBL27774544 0.81 ALDH1A1 (0.61) MAPTTDP1MEN1KMT2APOLB
SCHEMBL29655168 0.80 ERN1 (0.45) MAPTTDP1MEN1KMT2AALDH1A1
SCHEMBL9808940 0.80 MAPT (0.51) MAPTTDP1MEN1KMT2APOLB
SCHEMBL29655165 0.79 TDP1 (0.54) MAPTTDP1MEN1KMT2APOLB
Nitrogen SCHEMBL28840099 0.78 ALDH1A1 (0.58) MAPTTDP1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843874-B Phthalazine derivatives useful as inhibitors of PARP1, PARP2 and/or tubulin for the treatment of cancer 加利福尼亚大学董事会 2022-05-27 CN disclosed